⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for hereditary leiomyomatosis and renal cell carcinoma

Every month we try and update this database with for hereditary leiomyomatosis and renal cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell CancerNCT04603365
Clear Cell Papi...
Collecting Duct...
Hereditary Leio...
Hereditary Papi...
Metastatic Rena...
Metastatic Uncl...
Papillary Renal...
Stage III Renal...
Stage IV Renal ...
Tubulocystic Re...
Unresectable Re...
Pamiparib
Temozolomide
18 Years - Jonsson Comprehensive Cancer Center
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney CancerNCT04981509
Hereditary Leio...
Papillary Renal...
Renal Cell Carc...
Sporadic Papill...
Stage III Renal...
Stage IV Renal ...
Atezolizumab
Bevacizumab
Biopsy
Biospecimen Col...
Bone Scan
Computed Tomogr...
Computed Tomogr...
Erlotinib
Magnetic Resona...
Positron Emissi...
Sodium Fluoride...
12 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: